Renalytix Plc (RNLX)

USD 0.21

(5.66%)

Annual Income Statements

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 2.28 Million 3.4 Million 2.97 Million 1.49 Million - -
Cost of Revenue 2.13 Million 2.7 Million 2.05 Million 804 Thousand 74 Thousand 30.99 Thousand
Gross Profit 156 Thousand 701 Thousand 918 Thousand 687 Thousand -74 Thousand -30.99 Thousand
Operating Expenses 29.04 Million 43.05 Million 58.29 Million 33.29 Million 11.07 Million 6.53 Million
Selling, General and Administrative Expenses 19.75 Million 43.05 Million 12.95 Million 8.37 Million 11.07 Million 6.53 Million
Research and Development Expenses 9.29 Million 14.29 Million 14.64 Million 10.04 Million 4.56 Million 39.59 Million
Other Expenses 249 Thousand 656 Thousand 30.69 Million 14.88 Million - -
Cost and Expenses 31.17 Million 45.75 Million 60.34 Million 34.1 Million 11.07 Million 6.53 Million
Operating Income -29.6 Million -42.35 Million -57.37 Million -32.61 Million -11.07 Million -6.53 Million
Interest Expense - - 2000.00 3000.00 2000.00 20 Thousand
Income Tax Expense 4000.00 2000.00 25 Thousand - - -
Earnings before Tax -33.45 Million -46.22 Million -49.62 Million -35.78 Million -10.61 Million -6.51 Million
Net Income -33.45 Million -45.6 Million -45.27 Million -34.72 Million -9.84 Million -42.3 Million
Earnings Per Share Basic -0.31 -0.55 -0.62 -0.49 -0.17 -0.99
Earnings Per Share Diluted -0.31 -0.55 -0.67 -0.49 -0.17 -0.99
Weighted Average Shares Outstanding 108.17 Million 82.21 Million 67.98 Million 70.86 Million 57.9 Million 42.56 Million
Weighted Average Shares Outstanding (Diluted) 108.17 Million 82.21 Million 73.83 Million 71.48 Million 59.07 Million 42.56 Million
Gross Margin 0.07 0.21 0.31 0.46 - -
EBIT Margin -10.28 -10.43 -15.19 -26.43 - -
Profit Margin -14.62 -13.40 -15.24 -23.29 - -
EBITDA -28.52 Million -41.71 Million -52.69 Million -33.68 Million -11.07 Million -5.37 Million
Earnings Before Tax Margin -12.93 -12.45 -19.32 -21.87 - -

Income Statement Charts